We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
+2.38%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$1.04B
AUM Growth
+$128M
Cap. Flow
+$22.8M
Cap. Flow %
2.2%
Top 10 Hldgs %
26.5%
Holding
397
New
18
Increased
86
Reduced
236
Closed
20

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$3.31M
2
NOC icon
Northrop Grumman
NOC
+$1.77M
3
UNH icon
UnitedHealth
UNH
+$1.5M
4
GS icon
Goldman Sachs
GS
+$1.37M
5
MSFT icon
Microsoft
MSFT
+$1.25M

Sector Composition

Rank Sector Weight
1 Healthcare 14.41%
2 Financials 13.83%
3 Technology 12.87%
4 Industrials 8.32%
5 Consumer Staples 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EZU icon
1
iShare MSCI Eurozone ETF
EZU
$9.55B
$97.6M 9.42%
3,023,427
+39,977
+1% +$1.37M
AMJ
2
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$37.3M 3.6%
1,171,826
+1,048,038
+847% +$31.2M
JNJ icon
3
Johnson & Johnson
JNJ
$616B
$20.7M 2%
170,931
+1,744
+1% +$198K
AAPL icon
4
Apple
AAPL
$4.76T
$20.2M 1.95%
845,204
-36,236
-4% -$901K
CMCSA icon
5
Comcast
CMCSA
$84.9B
$18.2M 1.76%
559,416
+830
+0.1% +$25.8K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$17.4M 1.67%
119,835
+2,100
+2% +$300K
XOM icon
7
ExxonMobil
XOM
$640B
$16.9M 1.63%
179,940
-2,696
-1% -$238K
PFE icon
8
Pfizer
PFE
$142B
$16.5M 1.59%
494,068
-17,204
-3% -$549K
CVS icon
9
CVS Health
CVS
$139B
$15M 1.45%
157,178
-8,534
-5% -$851K
NOC icon
10
Northrop Grumman
NOC
$75.1B
$14.8M 1.43%
66,809
-8,397
-11% -$1.77M
AET
11
DELISTED
Aetna Inc
AET
$14.6M 1.41%
119,760
-1,527
-1% -$175K
INTC icon
12
Intel
INTC
$527B
$14.6M 1.41%
444,945
+123
+0% +$3.85K
UNH icon
13
UnitedHealth
UNH
$393B
$13.2M 1.27%
93,460
-11,250
-11% -$1.5M
MSFT icon
14
Microsoft
MSFT
$2.89T
$12.5M 1.2%
243,440
-24,139
-9% -$1.25M
CVX icon
15
Chevron
CVX
$384B
$12M 1.15%
114,040
-2,639
-2% -$265K
DIS icon
16
Walt Disney
DIS
$168B
$11.5M 1.11%
117,264
-1,966
-2% -$197K
T icon
17
AT&T
T
$159B
$10.8M 1.04%
330,305
+66,299
+25% +$1.97M
IWC icon
18
iShares Micro-Cap ETF
IWC
$1.46B
$10.7M 1.04%
151,803
-6,780
-4% -$473K
ED icon
19
Consolidated Edison
ED
$41.1B
$10.6M 1.02%
131,566
-1,691
-1% -$127K
TMO icon
20
Thermo Fisher Scientific
TMO
$194B
$10.5M 1.01%
70,960
-4,837
-6% -$714K
TRV icon
21
Travelers Companies
TRV
$82.3B
$10M 0.97%
84,230
-266
-0.3% -$30.1K
TWX
22
DELISTED
Time Warner Inc
TWX
$9.94M 0.96%
135,189
-3,299
-2% -$244K
AMGN icon
23
Amgen
AMGN
$199B
$9.9M 0.96%
65,071
+306
+0.5% +$47.6K
IBM icon
24
IBM
IBM
$196B
$9.69M 0.94%
66,769
-1,441
-2% -$206K
ELV icon
25
Elevance Health
ELV
$84.7B
$9.65M 0.93%
73,449
-3,031
-4% -$415K

Similar funds

RegentAtlantic Capital's Q2 2016 Portfolio in Review

As of Q2 2016, RegentAtlantic Capital held 397 positions worth $1.04B, up 14% from $909M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

RegentAtlantic Capital's Q2 2016 filing shows 18 new, 86 increased, 236 reduced and 20 closed positions. Its largest new stake was PPG Industries: 9,722 shares worth $1.01M. The largest sale was American International, an estimated $3.31M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

  • RegentAtlantic Capital's largest Q2 2016 buy was PPG Industries: 9,722 shares worth $1.01M.
  • RegentAtlantic Capital added most to JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2016, an estimated $31.2M increase.
  • RegentAtlantic Capital's biggest Q2 2016 reduction was American International, cutting an estimated $3.31M.
  • RegentAtlantic Capital fully exited Under Armour in Q2 2016, selling an estimated $314K.
  • RegentAtlantic Capital's ten largest holdings make up 27% of its $1.04B portfolio in Q2 2016.
  • RegentAtlantic Capital opened 18 new positions and closed 20 in Q2 2016.
  • RegentAtlantic Capital's portfolio value rose 14% quarter-over-quarter to $1.04B.

Based on RegentAtlantic Capital's 13F filing for Q2 2016, filed 18 Jul 2016.